The use of special approval medicines among pediatric patients in a tertiary care hospital: A reality check

BACKGROUND: Special approval medicines (SAMs) are medicines used with approval from the Director General of Health Malaysia when the therapeutic options within regulatory and formulary boundaries appear unsuitable or ineffective to treat the patients. OBJECTIVES: To examine and characterize the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Balan, Shamala, Koo, Kaitian, Muhamad Hamdan, Muhamad Danial, Lee, Su Vin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587311/
https://www.ncbi.nlm.nih.gov/pubmed/36281358
http://dx.doi.org/10.1016/j.rcsop.2022.100188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587311/
https://www.ncbi.nlm.nih.gov/pubmed/36281358
http://dx.doi.org/10.1016/j.rcsop.2022.100188

Ejemplares similares